LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) has shared an announcement.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced a halt in trading of its shares on the Hong Kong Stock Exchange due to recent fluctuations in share price and trading volume. The company attributes these movements to investor recognition of its continuous growth and performance, as well as the restoration of its value. The company has set ambitious sales targets for its occluder and transcatheter aortic valve replacement products, but acknowledges that achieving these targets is uncertain and dependent on market conditions. Trading is set to resume following this announcement.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the medical technology industry, focusing on products such as occluders and transcatheter aortic valve replacements. It is part of a larger group with shares listed on the Shenzhen Stock Exchange.
YTD Price Performance: -8.15%
Average Trading Volume: 308,491
Technical Sentiment Signal: Buy
For a thorough assessment of 2291 stock, go to TipRanks’ Stock Analysis page.